Beam Therapeutics Inc (BEAM)

Jun 22, 2026

Beam Therapeutics stock soars 21% in three months: Here's why - MSN

Jun 22, 2026

Jun 22, 2026

Beam Therapeutics president exercises 35,505 options | BEAM Insider Trading - Stock Titan

Jun 22, 2026

Jun 22, 2026

Beam Therapeutics stock hits 52-week high at 36.66 USD - Investing.com

Jun 22, 2026

Jun 22, 2026

Beam Therapeutics stock hits 52-week high at 36.66 USD By Investing.com - Investing.com Canada

Jun 22, 2026

Jun 22, 2026

BEAM Stock's Gains Fade Despite Promising Data Rare Liver Disease Treatment Data - Stocktwits

Jun 22, 2026

Jun 22, 2026

Clinical: Beam Advances Base Editing For PKU - CRISPR Medicine News

Jun 22, 2026

Jun 22, 2026

Beam Therapeutics Inc (BEAM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026

Jun 19, 2026

BEAM Stock Gains 5% as FDA Clears BEAM-304 IND for Phenylketonuria - Zacks Investment Research

Jun 19, 2026

Jun 18, 2026

BEAM News | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill

Jun 18, 2026

Jun 18, 2026

Beam Therapeutics (BEAM) Receives FDA Approval for BEAM-304 IND Application - GuruFocus

Jun 18, 2026

Jun 18, 2026

Beam gets FDA clearance for BEAM-304 PKU gene-editing trial - Stock Titan

Jun 18, 2026

Jun 18, 2026

Beam Therapeutics gets FDA clearance for BEAM-304 - grafa.com

Jun 18, 2026

Jun 18, 2026

Beam Therapeutics gets FDA clearance for PKU gene therapy trial - Investing.com

Jun 18, 2026

Jun 18, 2026

Beam Therapeutics Inc (BEAM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026

Jun 18, 2026

Beam Therapeutics gets FDA clearance for PKU gene therapy trial By Investing.com - Investing.com India

Jun 18, 2026

Jun 18, 2026

Beam Therapeutics Announces Clearance of Investigational - GlobeNewswire

Jun 18, 2026

Jun 18, 2026

BEAM Stock Price, Quote & Chart - ChartMill

Jun 18, 2026

Jun 18, 2026

Beam Therapeutics Inc (BEAM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026

Jun 17, 2026

Beam Therapeutics Inc (BEAM) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Beam Therapeutics Inc (BEAM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

Beam Therapeutics Inc (BEAM) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 16, 2026

Beam Therapeutics Stock Soars 21% in Three Months: Here's Why - The Globe and Mail

Jun 16, 2026

Jun 16, 2026

Is Beam Therapeutics Inc. (BEAM) One of the Best Genomics Stocks to Buy According to Analysts? - Yahoo Finance

Jun 16, 2026

Jun 14, 2026

5 Best Genomics Stocks to Buy According to Analysts - Insider Monkey

Jun 14, 2026

Jun 14, 2026

BEAM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 14, 2026

Jun 13, 2026

Precision Trading with Beam Therapeutics Inc. (BEAM) Risk Zones - Stock Traders Daily

Jun 13, 2026

Jun 10, 2026

Amova Asset Management Americas Inc. Cuts Stock Position in Beam Therapeutics Inc. $BEAM - MarketBeat

Jun 10, 2026

Jun 09, 2026

Geode Capital Management LLC Sells 39,035 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat

Jun 09, 2026

Jun 09, 2026

Beam Stockholders Back Board, Leadership at Annual Meeting - The Globe and Mail

Jun 09, 2026

Jun 08, 2026

Beam Therapeutics (Nasdaq: BEAM) shareholders approve directors, auditor and pay - Stock Titan

Jun 08, 2026

Jun 05, 2026

Beam Therapeutics Inc (BEAM) Stock Price, Quote, News & History - Benzinga

Jun 05, 2026

Jun 05, 2026

Beam Therapeutics (BEAM) director receives 19,676-share option grant - Stock Titan

Jun 05, 2026

Jun 05, 2026

Beam Therapeutics (BEAM) director receives stock options grant for 19,676 shares - Stock Titan

Jun 05, 2026

Jun 05, 2026

Beam Therapeutics (BEAM) grants 19,676 stock options to director - Stock Titan

Jun 05, 2026

Jun 05, 2026

Beam Therapeutics (BEAM) director receives stock options on 19,676 shares - Stock Titan

Jun 05, 2026

Jun 05, 2026

Beam Therapeutics (BEAM) awards stock options to director Chirfi - Stock Titan

Jun 05, 2026

Jun 05, 2026

Beam Therapeutics (BEAM) awards director Graham Cooper 19,676 options - Stock Titan

Jun 05, 2026

Jun 04, 2026

Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock - Investing.com

Jun 04, 2026

Jun 04, 2026

Beam Therapeutics (NASDAQ:BEAM) Trading 10.1% HigherWhat's Next? - MarketBeat

Jun 04, 2026

Jun 04, 2026

Wells Fargo Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $70 - Moomoo

Jun 04, 2026

Jun 04, 2026

Beam Therapeutics CEO Evans sells $739k in stock - Investing.com

Jun 04, 2026

Jun 03, 2026

BEAM Technical Analysis & Stock Price Forecast - Intellectia AI

Jun 03, 2026

Jun 03, 2026

Beam Therapeutics Stock Hits Day Low of $28.80 Amid Price Pressure - Markets Mojo

Jun 03, 2026

Jun 03, 2026

Beam Therapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus

Jun 03, 2026

Jun 03, 2026

Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Jun 03, 2026

Jun 02, 2026

Technical Reactions to BEAM Trends in Macro Strategies - Stock Traders Daily

Jun 02, 2026

Jun 02, 2026

Draft FDA guidance could be a boon for gene therapy developers - Seeking Alpha

Jun 02, 2026

May 30, 2026

Beam Therapeutics eyes sickle cell BLA as Alpha-1 gene-editing program advances - MSN

May 30, 2026

May 28, 2026

Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics? - AOL.com

May 28, 2026

May 28, 2026

Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum - Quantisnow

May 28, 2026

May 27, 2026

Beam Therapeutics (BEAM) Is Up 17.6% After Advancing BEAM-302 Toward Accelerated Approval in AATD - Yahoo Finance

May 27, 2026

May 25, 2026

Gene Editing Sector Gains Momentum with Key Players CRISPR and Beam - Intellectia AI

May 25, 2026